Journal of Medicinal Chemistry p. 466 - 472 (1988)
Update date:2022-07-29
Topics: In vitro Derivatives Antagonists in vivo High-Throughput Screening Pharmacokinetics Experimental terms Assay Platelet Activating Factor Pharmacodynamics
Tilley, Jefferson W.
Burghardt, Barbara
Burghardt, Charles
Mowles, Thomas F.
Leinweber, Franz-Josef
et al.
A series of N-<(heteroaryl)alkyl>pyrido<2,1-b>quinazolines were evaluated for their ability to inhibit the binding of radiolabeled platelet activating factor (PAF) to its receptor on dog platelets.The most potent compounds in this series were found to be
View MoreContact:18710867521(wechat)
Address:Rm10516,Galaxy Tech Building #2,No.25 Tangyan Rd,Hi-Tech Zone,Xi'an, China
Wuhan Better Organic Technology Inc.
Contact:13307163183
Address:Wuhan Economic&Technology Development Zone, Hubei
Zibo Fuxi'er Chemical Co.,Ltd （Shanxian Fuxi'er Chemical Co.,Ltd）
Contact:+86-533-2091422
Address:Eastern 4 on the 3th Road ,Liangxiang Industrial Park, Zibo city ,Shandong,China
Contact:+86-27-67841589
Address:Add: 999 Gaoxin Road, Donghu New Technology Development Zone, Wuhan City, Hubei, China
Chongqing Rong＆Quan Pharmaceutical Technology Co. , Ltd.
Contact:86-023-65268721
Address:No. 7, Manshanhong Village, Pingdingshan, Shapingba District, Chongqing Province, China
Doi:10.1021/jo00238a021
(1988)Doi:10.1021/ja01574a048
(1957)Doi:10.1039/c39830001082
(1983)Doi:10.1021/jo00238a041
(1988)Doi:10.1021/jo00249a001
(1988)Doi:10.1016/j.ejmech.2008.03.019
(2009)
